4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors

References

• Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58:389–462
   PubMed Web of Science ®Google Scholar
• Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 2009;60:77–84
   PubMed Web of Science ®Google Scholar
• Labar G, Wouters J, Lambert DM. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr Med Chem 2010;17:2588–607
   PubMed Web of Science ®Google Scholar
• Saario SM, Poso A, Juvonen RO, et al. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem 2006;49:4650–6
   PubMed Web of Science ®Google Scholar
• Mulvihill MM, Nomura DK. Therapeutic potential of monoacylglycerol lipase inhibitors. Life Sci 2013;92:492–7
   PubMed Web of Science ®Google Scholar
• Nomura DK, Morrison BE, Blankman JL, et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 2011;334:809–13
   PubMed Web of Science ®Google Scholar
• Kinsey SG, O’Neal ST, Long JZ, et al. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol Biochem Behav 2011;98:21–7
   PubMed Web of Science ®Google Scholar
• Ramesh D, Ross GR, Schlosburg JE, et al. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice. J Pharmacol Exp Ther 2011;339:173–85
   PubMed Web of Science ®Google Scholar
• Kopp F, Komatsu T, Nomura DK, et al. The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(−/−) mice. Chem Biol 2010;17:831–40
   PubMed Web of Science ®Google Scholar
• Long JZ, Li W, Booker L, et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009;5:37–44
   PubMed Web of Science ®Google Scholar
• Aaltonen N, Savinainen JR, Ribas CR, et al. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase. Chem Biol 2013;20:379–90
   PubMed Web of Science ®Google Scholar
• Muccioli GG, Labar G, Lambert DM. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay. Chembiochem 2008;9:2704–10
   PubMed Web of Science ®Google Scholar
• Ben Ali Y, Chahinian H, Petry S, et al. Use of an inhibitor to identify members of the hormone-sensitive lipase family. Biochemistry 2006;45:14183–91
   PubMed Web of Science ®Google Scholar
• Minkkila A, Savinainen JR, Kasnanen H, et al. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors. ChemMedChem 2009;4:1253–9
   PubMed Web of Science ®Google Scholar
• Patel JZ, Parkkari T, Laitinen T, et al. Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors. J Med Chem 2013;56:8484–96
   PubMed Web of Science ®Google Scholar
• Kasnanen H, Minkkila A, Taupila S, et al. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling. Eur J Pharm Sci 2013;49:423–33
   PubMed Web of Science ®Google Scholar
• Maestro, version 9.0. Portland (OR): Schrödinger Inc; 2009
   Google Scholar
• Macromodel, version 9.7. Portland (OR): Schrödinger Inc; 2009
   Google Scholar
• Verdonk ML, Cole JC, Hartshorn MJ, et al. Improved protein-ligand docking using GOLD. Proteins 2003;52:609–23
   PubMed Web of Science ®Google Scholar
• Bertrand T, Auge F, Houtmann J, et al. Structural basis for human monoglyceride lipase inhibition. J Mol Biol 2010;396:663–73
   PubMed Web of Science ®Google Scholar
• Mileni M, Kamtekar S, Wood DC, et al. Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation. J Mol Biol 2010;400:743–54
   PubMed Web of Science ®Google Scholar
• Erlenmeyer E. Ueber die Condensation der Hippursäure mit Phtalsäureanhydrid und mit Benzaldehyd. Ann Chim Pharm 1893;275:1–8
   Google Scholar
• Plöchl J. Über einige Derivate der Benzoylimdozimtsäure. Ber 1884;17:1616–24
   Google Scholar
• Rao YS. Reactions in polyphosphoric acid. I. New stereospecific synthesis of the E isomers of 2-phenyl-4-arylmethylene-2-oxazolin-5-ones. J Org Chem 1976;41:722–5
   Web of Science ®Google Scholar
• Miyaura N, Suzuki A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem Rev 1995;95:2457–83
   Web of Science ®Google Scholar
• Weber V, Rubat C, Duroux E, et al. New 3- and 4-hydroxyfuranones as anti-oxidants and anti-inflammatory agents. Bioorg Med Chem 2005;13:4552–64
   PubMed Web of Science ®Google Scholar
• King AR, Lodola A, Carmi C, et al. A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. Br J Pharmacol 2009;157:974–83
   PubMed Web of Science ®Google Scholar
• Tuccinardi T, Granchi C, Rizzolio F, et al. Identification and characterization of a new reversible MAGL inhibitor. Bioorg Med Chem 2014;22:3285–91
   PubMed Web of Science ®Google Scholar
• Nomura DK, Long JZ, Niessen S, et al. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010;140:49–61
   PubMed Web of Science ®Google Scholar
• Chanda PK, Gao Y, Mark L, et al. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol 2010;78:996–1003
   PubMed Web of Science ®Google Scholar
• Schlosburg JE, Blankman JL, Long JZ, et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 2010;13:1113–19
   PubMed Web of Science ®Google Scholar
• Busquets-Garcia A, Puighermanal E, Pastor A, et al. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry 2011;70:479–86
   PubMed Web of Science ®Google Scholar
• Chen R, Zhang J, Wu Y, et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer’s disease. Cell Rep 2012;2:1329–39
   PubMed Web of Science ®Google Scholar